Neuroinflammatory serum and cerebrospinal fluid (CSF) biomarkers associated with either microglia (soluble TREM2, monocyte chemoattractant protein-1 (MCP-1), and chitinase-3-like protein 1 (CHI3L1)) or astroglia (e.g., CHI3L1) are currently extensively investigated in AD patients [114]. The gene discussed is CCL2; the disease is Alzheimer disease.